Literature DB >> 1682474

Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.

K Ohki1, Y Kishi, Y Nishino, M Sumiya, T Kimura, T Goto, M Nakai, K Ikuta.   

Abstract

A defective doughnut-shaped human immunodeficiency virus type 1 (HIV-1)-producing cell clone (designated as L-2) was isolated from persistently HIV-1-infected MT-4 cells. The syncytium-forming capacity of the cell and virus particle fractions was examined in human CD4-positive T cells. Several cell lines producing infectious HIV-1 particles, such as persistently HIV-1-infected MOLT-4 (MOLT-4/HIV-1) cells, were used as controls. Syncytia were formed within 20 h by the cell fraction of both L-2 and MOLT-4/HIV-1 and the virus particle fraction of L-2, but not MOLT-4/HIV-1. These formations were not affected by 3'-azido-3'-deoxythymidine (ZDV). In contrast, similar syncytium formation was first observed 2 days after the incubation of the virus particle fraction of MOLT-4/LAV-1 and this syncytium formation mediated by the cell fractions of MOLT-4/HIV-1 and L-2 or the virus particle fraction of L-2 differently.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682474

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  7 in total

1.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 2.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells.

Authors:  M Kameoka; T Kimura; Y H Zheng; S Suzuki; K Fujinaga; R B Luftig; K Ikuta
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.

Authors:  Masanobu Kinomoto; Masaru Yokoyama; Hironori Sato; Asato Kojima; Takeshi Kurata; Kazuyoshi Ikuta; Tetsutaro Sata; Kenzo Tokunaga
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.

Authors:  Xiaozhuo Ran; Zhujun Ao; Adriana Trajtman; Wayne Xu; Gary Kobinger; Yoav Keynan; Xiaojian Yao
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  An HIV/AIDS Prophylactic vaccine is possible.

Authors:  Qiu Zhong; Ronald B Luftig
Journal:  J Immune Based Ther Vaccines       Date:  2007-12-19

7.  CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.

Authors:  Youdiil Ophinni; Mari Inoue; Tomohiro Kotaki; Masanori Kameoka
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.